Literature DB >> 21221112

Alzheimer disease: homocysteine and alzheimer disease: an intervention study.

Perminder S Sachdev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21221112     DOI： 10.1038/nrneurol.2010.195

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction.

Authors:  Frank M Faraci; Steven R Lentz
Journal:  Stroke       Date:  2004-02       Impact factor: 7.914

2.  Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.

Authors:  I I Kruman; C Culmsee; S L Chan; Y Kruman; Z Guo; L Penix; M P Mattson
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Dementia prevention: the discordance between observational and intervention studies and the search for more evidence.

Authors:  Perminder S Sachdev
Journal:  Early Interv Psychiatry       Date:  2009-02       Impact factor: 2.732

4.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

5.  Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

Authors:  P S Sachdev; M Valenzuela; X L Wang; J C L Looi; H Brodaty
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

Review 6.  B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.

Authors:  Alan D Dangour; Peter J Whitehouse; Kevin Rafferty; Stephen A Mitchell; Lesley Smith; Sophie Hawkesworth; Bruno Vellas
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys.

Authors:  Auriel A Willette; Catherine Gallagher; Barbara B Bendlin; Donald G McLaren; Erik K Kastman; Elisa Canu; Kris J Kosmatka; Aaron S Field; Andrew L Alexander; Ricki J Colman; Mary-Lou L Voytko; Richard H Weindruch; Christopher L Coe; Sterling C Johnson
Journal:  Neurobiol Aging       Date:  2010-08-05       Impact factor: 4.673

8.  Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Authors:  A David Smith; Stephen M Smith; Celeste A de Jager; Philippa Whitbread; Carole Johnston; Grzegorz Agacinski; Abderrahim Oulhaj; Kevin M Bradley; Robin Jacoby; Helga Refsum
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

Review 9.  Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature.

Authors:  T Vogel; N Dali-Youcef; G Kaltenbach; E Andrès
Journal:  Int J Clin Pract       Date:  2009-07       Impact factor: 2.503

Review 10.  Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.

Authors:  Reem Malouf; John Grimley Evans
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08
  10 in total
  2 in total

Review 1.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

2.  Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects.

Authors:  Xinyu Mei; Dashi Qi; Ting Zhang; Ying Zhao; Li Jin; Junli Hou; Jianhua Wang; Yan Lin; Yu Xue; Pingping Zhu; Zexian Liu; Lei Huang; Ji Nie; Wen Si; Jingyi Ma; Jianhong Ye; Richard H Finnell; Hexige Saiyin; Hongyan Wang; Jianyuan Zhao; Shimin Zhao; Wei Xu
Journal:  EMBO Mol Med       Date:  2020-01-31       Impact factor: 12.137
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.